Syngulon
- Type
- Technology Company
- Location
- Charleroi, Belgium
- Industries
- Food safety & quality
- Domains
- Algae, Plant based primary products, Proteins, Ingredients
- Technologies
- Microbial biotechnology, Biotechnology & sustainable inputs
About Syngulon
Syngulon is a biotechnology company focused on bacteriocin-based technologies. Its website presents bacteriocins as small antimicrobial peptides with potential industrial applications, especially where precise control of bacterial growth is needed.
The company positions itself at the intersection of microbiology, synthetic biology, and applied industrial use. It highlights bacteriocins as an alternative to broad-spectrum antibiotics and as a tool for reducing unwanted microbial contamination while supporting more targeted, controllable processes.
Core Values
- Targeted antimicrobial action: Syngulon emphasizes the narrow specificity of many bacteriocins, which can help control unwanted bacteria without relying on broad-spectrum antibiotics.
- Antibiotic reduction: A recurring theme on the site is reducing antibiotic use in both medical and industrial contexts to help address antimicrobial resistance and lower environmental antibiotic release.
- Scientific rigor: The company grounds its work in academic research, citing published studies and laboratory observations to support the relevance of its technologies.
- Industrial practicality: Syngulon presents bacteriocins not only as a scientific topic but as a practical tool for production systems, contamination control, and process efficiency.
Unique Aspects
- Specialization in bacteriocins: Syngulon is unusually focused on bacteriocins as a core technology platform, rather than treating them as one ingredient among many.
- Academic research roots: The company’s narrative is closely tied to university research and published scientific work, including studies on bacteriocin regulation and activity.
- Potential for both industrial and therapeutic use: Syngulon presents bacteriocins as relevant to food and industrial microbiology as well as to future medical applications against resistant pathogens.
- Antibiotic-free selection approach: Its antibiotic-free E. coli selection technology is a distinctive application of bacteriocin biology that addresses a common laboratory and bioprocessing need.